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Abstract-The costs of home care in the Netherlands are estimated for women with advanced breast and 
cervical cancer. We observe a growing role of intensive home care for the terminally ill patients. The 
average costs of home care are dfl 8500 per patient for breast cancer patients and dfl 7200 for cervical 
cancer patients. More than half of these costs are incurred in the last month before death. The level of 
home care in the preceding months is quite modest (dtl 120 per month for both diseases), not taking into 
account informal care. The costs of home care for patients with advanced cancer are only slightly related 
to the site of the primary tumor from which the metastases originate. Total average costs per patient 
during advanced isease, including hospital and nursing home care, amount to dfl42.700 for breast cancer 
and dfl 29,000 for cervical cancer. This difference in costs is largely attributable to the longer duration 
of advanced disease for breast cancer, which substantially affects hospital costs. The high costs of care 
to patients with advanced cancer contribute to a favourable cost-effectiveness ratio of those screening 
programmes which reduce mortality and consequently the costs of care to advanced cancer patients. 
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INTRODUCTION 
In this article we estimate the costs of home care in 
the Netherlands for patients with advanced breast 
or cervical cancer. The role of home care in 
treating cancer is becoming more important in the 
Netherlands, but so far a reliable estimate of the costs 
of home care per patient is lacking internationally. 
Data on home care related to patient character- 
istics as age, sex and diagnosis are scarce for the 
Netherlands. Recently, detailed data became 
available on intensive home care in three Dutch 
regions for patients in the terminal phase of disease 
[l]. Combined with information of other surveys 
concerning home care we derived a global estimate of 
the total costs of home care during the period of 
advanced disease. During this period, women can 
stay alternatively at home, in a hospital or in a 
nursing home. Staying at home the patient may 
receive professional and/or informal care. 
Professional care in the Netherlands is mainly 
delivered by district-nurses, home helps, general 
practitioners and private nurses. Informal care is 
defined as care provided by relatives, neighbours, 
friends and volunteers. 
Although the amount of care varies considerably 
between individual women with cancer, in general the 
intensity of home care is low at the start of the period 
of advanced disease and initially increases only 
gradually. The level of care rises rapidly in the last 
months before death and remains high. This care 
pattern also holds for hospital care [2-51. 
First, we estimated the costs of home care for 
advanced disease, taking into account the role of 
professional as well as informal care. These costs were 
combined with information on the costs of hospital 
and nursing home care to arrive at the total costs for 
patients with advanced breast and cervical cancer. 
Finally, the results were used to illustrate the 
sensitivity of cost-effectiveness ratios of screening for 
breast and cervical cancer to variation in the costs of 
care to patients with advanced cancer. 
MATERIALS AND METHODS 
The advanced stage of breast and cervical cancer is 
defined here as starting when metastasis or recurrence 
of the tumor are clinically detected and terminating 
when the patient dies. The length of the period of 
advanced disease was estimated by a detailed analysis 
of hospital files of 68 women having advanced breast 
cancer and 35 women with advanced cervical cancer. 
The average length of advanced cancer was estimated 
at 21 months for breast cancer and 11 months for 
cervical cancer [6,7]. 
As stated before initially the level of home care will 
be relatively low, in general, but it will rise rapidly in 
the last months before dying. Figure 1 illustrates this 
pattern. The total amount of home care provided is 
represented by the area under the solid line in Fig. 1. 
It could be calculated using exact data on care for 
each patient over the entire course of advanced 
disease. The amount of care can be approximated by 
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Fig. I. Illustration of the pattern of home care for women 
with advanced cervical cancer. 
summing the estimated amount of care in each 
episode, as illustrated by the areas under the dashed 
lines in Fig. I. The available data enabled us to 
discern two episodes, the initial episode (M-T) and 
the terminal episode (T-O). 
Our definition of the term ‘terminal episode’ 
originates from the Dutch Intensive Homecare 
Project. In this project care is provided up to a 
maximum of 3 months. The ‘initial episode’ 
consequently is defined as the time-span before the 
terminal episode. 
In order to calculate the total costs of home care 
we estimated for each episode and for each type of 
care the following variables: the length of the episode, 
the proportion of patients receiving home care, the 
care-intensity and the costs per unit of care. Table I 
provides an overview of the Dutch studies on home 
care, which were used to estimate the costs of home 
care for advanced breast and cervical cancer. 
The terminal episode will be discussed first. 
Terminal episode 
The Intensive Homecare Project ([HP), since 1987 
in the Netherlands operating in an experimental 
setting in three regions: Amsterdam. West-Brabant] 
Zeeuws Vlaanderen and Groningen, covering 13% of 
the population (see Table I), provided data about 
intensive home-care for terminally ill patients in 1988 
[I 1. This project aims at patients who would otherwise 
be in need of hospital or nursing home care and for 
whom informal care is available (62% of the patients 
have advanced cancer). The amount of professional 
and informal care provided was registered daily. 
We used data for 1988 about intensive home care 
for 67 patients having advanced breast cancer and 32 
patients with advanced cancer of the female genital 
organs (cervical cancer was not discerned as a separ- 
ate diagnosis). The number of female cancer patients 
in the study period was 294. As Table I shows, the 
age-distribution of the women with breast cancer and 
all cancers together was very alike. Women having 
cancer of the female genital organs were on average 
slightly older. 
A substantial part of terminally ill patients staying 
at home only received ‘regular’ home-care which is 
less intensive than the IHP-care. We used two data 
’ : 
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sources to calculate the amount of ‘regular’ home 
care: a study of district nursing care in the evening 
and night for 134 women with cancer in the city of 
Amsterdam and data about the level of regular care 
for 80 patients with breast and female genital cancer 
in the last week before entering the IHP [S, 91, see 
Table 1 for details on the surveys. The care-intensity 
for these two groups appeared to be remarkably 
similar. 
Initial episode 
Data about home-care in the initial episode are 
scarce. Representative samples taken in 1986, 1987 
and 1988 by the National Association of District- 
nursing provided data for 10,000 patients on the 
amount of district nursing in seven rural and urban 
regions during one month each year, see Table 1 [14]. 
The amount and type of care and patients charac- 
teristics are registered in detail by district nurses. 
We pooled the data from the three samples, 
because there were no large differences in design and 
outcomes. 
Again the patients selected were women with breast 
cancer and cancer of the female genital tract as main 
diagnosis. Women labelled by the nurses as terminal 
patients in this registration were excluded from the 
sample, resulting in 134 women with breast cancer 
and 35 with female genital cancer in the period 
19861988. The age-distribution of these women is 
comparable to the women receiving intensive home 
care, see Table I. 
We used the average number of patients per sample 
receiving district nursing care and the care-intensity 
found as estimates for the average amount of district 
nursing in the initial episode. 
National data about home help only provide 
information about the average level of care by age- 
group [IO]. Additional research at one home help 
agency revealed more diagnosis-specific information 
[I I]. Data on care supplied by general practitioners, 
private nurses and informal care were not available 
for the initial period. 
Costs per hour of care for the relevant types of 
professional care were calculated for the year 1990, 
taking into account the relation between patient time 
and total working time, the costs of indirect person- 
nel, allowances for work beyond office hours and 
costs of nursing equipment [IO, 12-141. Informal care 
has also been valued. According to economic theory, 
two valuation methods can be used: the opportunity 
cost method and the market value approach. The first 
assesses the individual value of the time sacrificed by 
the care provider. An estimate of this value requires 
very detailed data on the preferences of informal care 
suppliers. Using the actual amount of care provided 
by informal care suppliers to determine the value of 
time invested may lead to biased estimates. If the 
informal care supplier is completely free in choosing 
the amount of care the value of time sacrificed could 
be estimated. The often limited availability of 
professional care may induce informal care suppliers 
to provide more care than they would supply if they 
were free to choose. which can easily lead to underes- 
timating the value (and costs) of informal care [15]. 
Instead we used the market value approach valuing 
the costs of informal care from a more social point 
of view [l6]. The price of professional care is used as 
the shadow-price for informal care reasoning that if 
informal care is not available, it has to be substituted 
by professional care. On average informal care 
providers will have a lower productivity than 
professionals and they will carry out more easy tasks. 
We roughly corrected for this by using the costs of the 
cheapest type of home help which closely resemble 
the market price of household services. 
RESULTS 
Terminal episode, intensive home care 
Length of episode. Sixty-seven women having 
advanced breast cancer as well as 32 women with 
metastases of cancer of the female genital tract 
received on average 3 weeks of intensive home-care in 
the IHP. This 3-week period applies also to the total 
group of 294 female cancer patients. The variance 
in episode length is considerable (see standard 
deviation). The distribution is highly skewed to the 
left as indicated by the value of the median which is 
small compared to the mean. This pattern holds for 
all variables estimated, but it is a quite common 
phenomenon in health care consumption: many 
‘modest’ consumers and relatively few ‘large’ 
consumers. 
Proportion of women receiving care. Assuming 
nationwide coverage of the intensive home care 
programme, which by now is being effectuated and 
taking into account the number of breast and cervical 
cancer deaths per year gives an estimation of 30% 
and 27% respectively of the terminal patients 
receiving intensive home care (see Tables 2a and b). 
Only a small minority of these women did not die at 
home, but went to a hospital or nursing home after 
receiving home care, for which we corrected. 
Care intensity. On average the breast cancer 
patients received 34 hr district nursing per week, I6 hr 
home help, 1 I hours private nursing, I.5 hr GP care 
and 45 hr informal care (Table 2a). For cancer of the 
female genital tract the figures were similar (see Table 
2b). The amount of care provided by physiotherapists 
and social workers turns out to be negligible. IHP- 
data and international literature indicate that in case 
of advanced cancer the site from which metastases 
originate does not significantly influence the amount 
of care and costs [2, 5, 12, 171. 
Costs per hour of care. The costs per hour 
for district nursing are significantly higher than for 
home help. The costs per hour for general 
practitioners are the highest, but the amount of care 
is quite modest. 
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Table 2(a). Estimates for lenglh. par~ic~patmn and intensiry of home care for breast cilncer patxnts having 
advanced disease. averaee values (medians and standard deviations in oxentheses) 
Initial eplsodr 
Terminal episode 
Inlensive care Regular care 
Vanable Average (median. SD) 
Epwde length 20 (19. 16) months 
Proportion of putienrs recmmg home carr 
District nursing 22%’ each month 
Home help 10%’ each month 
Awrage (medun. SD) 
22 (9. 28) days 
30%** 
30%‘. 
Average (median. SD) 
22 (9, 28) days 
20% l l 
20%” 
Care intrns~t~ in hours 
District nursing 3.5 (1.5, 6.4) per month 
Home help 4 (3.7, 4.5) per month 
Private nursing NA 
GP NA 
Informal case NA 
Costs per hour in Durch guilrkrs (1990) 
District nursing 75 
Home helf 36 
Private nursing 61 
GP 110 
34(29. 27) per week 
16(12, 15) per week 
I I (9. 7) per week 
l.S(l. 1.4) per week 
45 (32. 40) per week 
86 89 
46 42 
71 71 
I IO II0 
8 (6.5. 6 5) per week 
IO (6. I I) per week 
NA 
I (0.8, 1.5) per week 
45 (32, 40) per week 
Informal care I2 I2 I2 
*Each month 22% and 10% respectively of the women receive this care in the initial episode. 
**30% respectively 20% of all terminal patients are dying at home. receiving intensive resp. regular 
home-care. On average lhis care consists of the hours mentioned per lype of care. 
NA = assumed to be zero. because no data were available (see sensitivity analysis). 
Table 2(b). Estimates for length. participation and intensity of home care for cervical cancer patients having 
advanced disease, average values (medians and standards deviations in parentheses) 
Terminal episode 
lntial episode Intensive care Regular care 
Variable Average (median. SD) Average (median. SD) Average (median, SD) 
Episode length IO (6, 9) months 21 (12. 21) days 21 (12. 21) days 
Proporrion of parirnr.r rewiring home care 
District nursing 22%’ each month 27%” ‘3%** 
Home help IO%* each month 27%*’ 23%*’ 
Care inrmsity in hours 
District nursing 3 (I .5. 3.3) per month 29 (25, 20) per week 8 (6. 5.5) per week 
Home help 5 (4.2, 5) per month 20(16. 16) per week IO (7. 8) per week 
Private nursing NA 19(16. 15) per week NA 
GP NA 1.5(1. 1.4) per week I (0.8, 1.5) per week 
Informal care NA 43 (30. 41) per week 43 (30, 41) per week 
Cosrs per hour in Durrh guilders (1990) 
Distnct nursing 75 81 86 
Home help 36 47 42 
Private nursing 61 73 69 
GP II0 II0 II0 
Informal care I? I2 I? 
*Each month 22% and 10% respectively of the women receive this care in the initial episode. 
l *27% respectively 23% of all terminal patienrs die at home receiving intensive respectively regular home-care. 
On average this care consists of the hours mentioned per type of care. 
NA = assumed to be zero. because no data were available (see sensitivity analysis). 
Terminal episode, regular home care 
Still a substantial part of the terminally ill patients 
is dying at home without intensive home care. They 
are receiving informal care and possibly professional 
care, but less than the maximum amount of regular 
care. 
Length ofepisode. This is assumed to be 3 weeks as 
for intensive home care. 
Proporrion of women receiving care. The number of 
women dying at home with regular care follows from 
the total number of deceased minus the number of 
patients dying in hospitals and nursing homes and at 
home with intensive care. At this moment the 
calculation cannot be carried out exactly. The most 
recent, national and regional, statistics on the number 
of women dying in hospitals and nursing homes 
doesn’t yet reflect the influence of the recent regional 
intensive home care project. Therefore it is not known 
exactly how many women receiving intensive home 
care substituted this care for hospital and nursing 
home care or on the other hand received intensive 
home care instead of regular home care. For an exact 
estimation both flows should be analyzed. For the 
moment we assumed the proportions as mentioned in 
Table I, based on the most recent available 
information. 
Costs of home care for advanced breast and cervical cancer 983 
Cure intensity. Data on care for patients staying at 
home in the week before entering IHP and outcomes 
of the Amsterdam study on district nursing indicate 
that for this group of patients the average level of care 
is substantially lower than in cases of intensive home 
care [8,9]. On average patients received 8 hr district 
nursing, 10 hr home help and 1 hr GP care per week, 
which is considerably less than in cases of intensive 
home care, see Table 2(a) and (b). Data concerning 
private nursing are not available from these studies, 
not surprisingly as private nursing has only very 
recently become important in the Netherlands. 
The intensity of informal care is also unknown. We 
assumed it to be 45 hr per week, as we had found for 
intensive home care. On the one hand it could be 
argued that these patients require less help because 
they don’t need hospital care. On the other hand it is 
plausible that they are able to stay at home due to the 
large availability of informal care. 
Costs per hour of cure. The costs are almost 
identical as for intensive home care. Only small 
differences emerge as a result of a slightly different 
distribution between care during office hours, evening 
and night. 
Initial episode 
Length of episode. The initial episode lasts on 
average 20 months for breast cancer and 10 months 
for cervical cancer; this is calculated as the total 
period of advanced disease according to the hospital 
patient files [6,7], minus the terminal episode, 3 weeks 
(see Table 2a and b). 
Proportion of women receiving care. The data about 
district nursing only allow an estimation of the 
average proportion of women in the initial episode 
receiving district nursing care in any month. At any 
moment during the initial episode 22% (equal for 
both diseases) of these women are receiving district 
nursing care. The average care-intensity per patient is 
relatively low, 3-3.5 hr per month. In the same way 
the proportion of women receiving home help is 
assumed to be 10% for both diseases. 
Care intensity. The intensity of home help for 
women with advanced cancer is better documented 
and was estimated as 4 (breast cancer) respectively 
5 hr (cervical cancer) per week, which is slightly 
higher than for the average client receiving home 
help. No specific information is available for estimat- 
ing the amount of informal care, private nursing and 
care of general practitioners, which is a serious 
shortcoming. With respect to informal care only 
rough, not disease-specific estimates exist (191 which 
are not likely to reflect the situation of a patient 
during the initial episode of advanced cervical cancer. 
The average intensity of care during the initial 
episode turns out to be quite modest compared with 
the terminal episode, see Tables 2(a) and (b). 
Costs per hour of care. The costs per hour for 
nursing and home help are lower than in the terminal 
episode, because most care is given during office 
hours. 
Total costs of home care 
Combining the estimates of the four relevant vari- 
ables for both episodes gives the costs of home care 
as shown in Table 3. The average costs of home care 
per patient having advanced breast cancer are just 
over 8500 guilders, for cervical cancer 7200 guilders. 
More than half of the total costs are incurred by the 
intensive home care in the terminal episode. The 
higher costs for breast cancer are largely caused by 
greater length of the initial episode: 20 vs 10 months, 
as the costs of home care per month in the initial 
episode are approx equal for both disease: dtl 120. 
The district nursing and home help take the lion’s 
share of costs. Informal care takes 10% of the total 
costs for both diseases. If reliable data were available 
about informal care in the initial episode the share of 
informal care costs could be higher, raising total costs 
as well, see the sensitivity analysis. 
These outcomes can not easily be compared with 
results from other studies for two reasons: firstly, 
most studies don’t incorporate intensive home care 
and secondly analyses of costs of home care often 
don’t discern patients having different ypes of cancer. 
Total costs of advanced disease 
Separate studies on the costs of in hospital care and 
nursing home care have been carried out in the 
context of cost-effectiveness analysis on screening for 
breast and cervical cancer. Total average costs per 
patient having advanced disease range from dfl 
Table 3. Average costs for home care per patient with advanced 
breast and cervical cancer. Costs per type of care and episode in 
Dutch guilders (1990). Informal care also shown in hours 
Terminal episode 
Initial Total 
episode Intensive Regular costs 
fIreasr Cancel 
Type of care 
District nursing 
Home help 
Private nursing 
GP 
Material costs 
Total professional care 
Informal care 
Total costs 
Informal care (hr) 
Type of care 
District nursing 
Home help 
Private nursing 
GP 
Material costs 
Total professional care 
Informal care 
Total costs 
fll50 
f 1270 
f 0’ 
f 0” 
f 2420 
f 0’ 
f 2420 
0’ 
f 500 
f 770 
f 0’ 
f V 
f 1270 
f (r 
f 1270 
2640 430 
660 250 
700 v 
I50 70 
4150 750 
490 320 
4640 1070 
41 27 
1910 480 
760 290 
II20 v 
130 80 
3920 850 
420 360 
4340 I210 
2890 
1820 
II20 
210 
400 
6440 
780 
7220 
65 Informal care (hr) Q 35 30 
‘Assumed to be zero because no data were available (see sensitivity 
analysis). 
4220 
2180 
700 
220 
400 
7720 
810 
8530 
68 
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42.700 for breast cancer to dfl 29.000 for cervical 
cancer [6, 71. For both diseases the hospital bill is 
responsible for the greatest share in total costs. Costs 
of home care take 20-25% of the total costs. in spite 
of the trend towards substituting home care for 
hospital care which has been incorporated. 
Cost-eflectitieness of screening 
Using the average costs per patient for treating 
advanced disease, we can illustrate the influence of 
screening on the total treatment costs of advanced 
disease. Screening can prevent deaths of both types of 
cancer and therefore yields savings in the costs of 
treating advanced cancer: dfl 262 million for breast 
cancer and 47 million for cervical cancer, see Table 4. 
The cost-effectiveness of screening vs no screening 
can be expressed in the costs per life-year gained: dfl 
7500 in case of breast cancer and more than dB 2 1,600 
for cervical cancer, see Table 4 [IS, 201. 
The costs of home care take one fifth of the total 
costs of advanced disease for breast cancer and one 
fourth for cervical cancer. Ignoring these costs would 
lead to underestimation of the costs savings in 
treatment of advanced cancer as a result of screening. 
Consequently the costs of screening per life-year 
gained would be overestimated by 5% (cervical 
cancer) to 10% (breast cancer). 
SENSITIVITI’ ANALYSIS 
Sensitivity analysis was done regarding the 
proportion of women receiving district nursing care 
and home help in the initial episode. Halving the 
proportion of patients receiving district nursing care 
in the initial episode results in dfl 7955 for the costs 
Table 4. Costs. effects and cost-elkr~venest of screening breast 
cancer and cervical cancer; compared with no screening 
Breast cancer” err\ Ical cancerb 
No NO 
Screening screening Screenmg screening 
COJ IS 
Screening 599 _ 325 
Assessment and 4384 426 I 231 223 
pr. treatment 
Advanced disease 
Hospital care 2506 2715 I28 166 
Home care 626 679 30 39 
Total cosu 8115 7655 714 428 
Incremen1al costs 460 286 
Ejfeecticenurs 
Life-years gained 6 I.000 13.300 - 
Cost -efle~rkene.cs 
Costs per life-year 7500 31.600 
gained ( x 1000 dt7) 
‘Source: de Koning ct ul.. 1991: 
%urce: Koopmanschap et ul.. 1990. 
Costs in millions of guildcrs (1990). Discount rate 5% per year. 
Screening pohcies: breast cancer age 50-70. interval 2 years; 
cervical cancer age 37-73. interval 6 years. Screening during 
199~2017 
of home care in case of breast cancer, a decline of 7%. 
For cervical cancer total costs become dtl 6900 
(-3%). Our estimate of the proportion of women 
receiving home help was quite conservative. Doubling 
this proportion makes the total costs for breast 
cancer dfl 9800 (+ 15%) and for cervical cancer dfl 
7850 (f II%). Quite dramatic changes in these 
assumptions don’t cause great differences in the total 
costs for the advanced stage of both diseases. 
Valuing informal care is not an undisputed issue. 
If only costs of professional care are taken into 
account the average costs of home care per patient 
become dfl 7720 for breast cancer (- 9%) and dfl 
6440 for cervical cancer (- I 1%). 
The amount of care in the initial episode provided 
by private nursing, general practitioners and informal 
care was assumed to be zero, due to lack of data, 
which is quite unsatisfactory. If we impute conserva- 
tive guesses of the amount of care (1 hr per month 
private nursing and GP-care and IO hr per week 
informal care for both diseases) the costs of home 
care are the following: dfl 10,320 for breast cancer, an 
increase of 21% and dfl8 I I5 in case of cervical cancer 
(+ 12%). For breast cancer this results in a 
substantial increase in costs. 
We also lack a sound empirical basis for the 
amount of private nursing for terminal patients who 
receive only regular care. Assuming 5 hr care per 
week results in only a minor change in results, a 3% 
increase in costs of home care for both diseases. 
DISCUSSION AND CONCLUSIONS 
Reliable data on home care with respect to 
advanced cancer patients are very scarce, both in the 
Netherlands and in other countries. Available infor- 
mation mostly concerns care in the terminal episode 
of advanced disease. Although the lion’s share of 
home care costs is incurred during the terminal 
episode, home care in the initial episode is docu- 
mented less completely, making further research 
necessary. This research should preferably include 
monitoring of hospital and home care for individual 
women from the moment of detection of metastases 
until death, including daily registration of informal 
care. 
Because in the study period intensive home care 
was only recently introduced, we were not able to 
calculate the exact consequences of a nationwide 
implementation of intensive home care for the 
proportions of women dying in the hospital. nursing 
home or at home receiving intensive or regular care. 
Further analysis of the exact extent of substitution 
between intramural care and intensive home care and 
on the other hand substitution between regular home 
care and intensive home care is necessary. 
Despite these data problems, this analysis provides 
an adequate indication of the magnitude of the costs 
of home care for these diseases. The average costs of 
home care per patient range from dfl 7200 in case of 
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cervical cancer to dfl 8500 for breast cancer. More 
than half of these costs is incurred in the last month 
before death. These costs make up 20-25% of the 
total costs per patient with advanced disease. 
The data clearly show that the average costs of 
home care per patient for advanced cancer do not 
vary much between breast and cervical cancer. The 
costs of home care in the terminal episode are almost 
equal for both diseases (dfl 5700 vs 5500) and don’t 
diverge from the costs of other types of advanced 
cancer in women. The higher costs of home care in 
the initial episode for breast cancer (dfl 2400) 
compared with cervical cancer (dfl 1300) are caused 
by the different length of advanced disease. The 
average costs of home care per month during the 
initial episode are equal for both diseases (dfl 120). 
The costs of home care in advanced disease turn 
out to be important and influence the cost-effective- 
ness of screening for these diseases. Some uncertainty 
remains with respect to the degree of precision of our 
cost estimates of home care, but it does not influence 
the cost-effectiveness of screening substantially. 
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